Quorum Health (NYSE:QHC) was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday, June 21st.
Separately, Zacks Investment Research lowered Quorum Health from a “hold” rating to a “sell” rating in a research report on Wednesday, April 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $4.05.
NYSE:QHC opened at $5.00 on Thursday. The stock has a market capitalization of $152.10 million, a P/E ratio of -3.85 and a beta of 1.23. Quorum Health has a 1-year low of $2.91 and a 1-year high of $10.00. The company has a quick ratio of 1.51, a current ratio of 1.64 and a debt-to-equity ratio of 76.50.
Quorum Health (NYSE:QHC) last posted its quarterly earnings data on Wednesday, May 9th. The company reported ($0.80) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.48) by ($0.32). The company had revenue of $486.80 million for the quarter, compared to analyst estimates of $467.80 million. Quorum Health had a negative net margin of 9.14% and a negative return on equity of 46.79%. The business’s revenue was down 7.7% compared to the same quarter last year. During the same quarter last year, the company earned ($0.99) EPS. analysts predict that Quorum Health will post -1.68 earnings per share for the current fiscal year.
Several institutional investors and hedge funds have recently made changes to their positions in QHC. Koch Industries Inc. purchased a new position in shares of Quorum Health in the 1st quarter valued at about $103,000. Wells Fargo & Company MN lifted its stake in Quorum Health by 151.2% during the fourth quarter. Wells Fargo & Company MN now owns 27,996 shares of the company’s stock worth $175,000 after purchasing an additional 16,849 shares during the last quarter. Element Capital Management LLC purchased a new stake in Quorum Health during the first quarter worth approximately $194,000. Citadel Advisors LLC lifted its stake in Quorum Health by 150.5% in the fourth quarter. Citadel Advisors LLC now owns 31,933 shares of the company’s stock valued at $199,000 after buying an additional 19,183 shares during the last quarter. Finally, Jane Street Group LLC lifted its stake in Quorum Health by 130.5% in the first quarter. Jane Street Group LLC now owns 24,323 shares of the company’s stock valued at $199,000 after buying an additional 13,771 shares during the last quarter. Institutional investors and hedge funds own 90.17% of the company’s stock.
Quorum Health Company Profile
Quorum Health Corporation provides hospital and outpatient healthcare services in the United States. Its hospital and outpatient healthcare services include general and acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetric, diagnostic, psychiatric, and rehabilitation services.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with MarketBeat.com's FREE daily email newsletter.